Fig. 1: TP53 mutations predict poor outcomes in ALL.
From: Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults

A Overall and relapse-free survival curves for B-ALL patients with different molecular subtypes of disease. Multivariable analysis of overall survival for patients with B-ALL (B) and T-lineage ALL (C). Survival outcomes of B-ALL (D) and T-lineage ALL (E) patients stratified based on their TP53 status. CI confidence interval, HR, hazard ratio, OS overall survival, WT wild type.